ClinicalTrials.Veeva

Menu

Randomized Trial: High Power Short Duration Versus Ablation Index

R

Robert Bosch Medical Center

Status

Completed

Conditions

Atrial Fibrillation Paroxysmal
Catheter Ablation

Treatments

Other: Pulmonary vein isolation

Study type

Interventional

Funder types

Other

Identifiers

NCT05251545
High power - short duration

Details and patient eligibility

About

The single procedure success rates of durable pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) varies between 80 and 90 %.

This prospective, randomized study investigated the efficacy of pulmonary vein isolation with RF-energy following the CLOSE protocol with standard energy application (30 Watts) versus PVI with RF-energy with high power settings (45 Watts).

Full description

A total number of 176 patients undergoing de-novo catheter ablation for paroxysmal AF are planned to be randomized to two different treatment arms. In group-A patients, PVI was performed with RF-energy with standard power settings of 30 Watts in a temperature-controlled mode.

The ablation procedure in group B was performed with RF-energy with higher power settings of 45 Watts. In both groups the ablation is performed with ablation index (AI) and following the CLOSE protocol (AI and ≤ 6 mm interlesion distance using a surround flow catheter, Biosense Webster Thermocool STSF).

A total of 88 patients are planned to be randomized into each group, the follow-up period will be 12 months after the first procedure.

The primary endpoint is freedom of all atrial arrhythmias after one procedure. The secondary endpoint is procedural time. The third endpoint is safety.

Enrollment

176 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Paroxysmal atrial fibrillation
  • written informed consent

Exclusion criteria

  • inability to obtain written informed consent
  • persistent atrial fibrillation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

176 participants in 2 patient groups

High power - short duration
Active Comparator group
Description:
Pulmonary vein isolation with high power settings of 45 Watts
Treatment:
Other: Pulmonary vein isolation
Standard energy
Active Comparator group
Description:
Pulmonary vein isolation with standard power settings (30 Watts)
Treatment:
Other: Pulmonary vein isolation

Trial contacts and locations

1

Loading...

Central trial contact

Peter Ong, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems